Predictors of metformin monotherapy failure in gestational diabetes mellitus

OBJECTIVE: Metformin has emerged as a safe and effective pharmacological alternative to insulin in gestational diabetes mellitus (GDM), being associated with lower maternal weight gain and hypoglycemia risk. Nevertheless, glycemic control is unaccomplished in a considerable proportion of women only...

Descripción completa

Detalles Bibliográficos
Autores principales: Benido Silva, Vânia, Fonseca, Liliana, Pereira, Maria Teresa, Vilaverde, Joana, Pinto, Clara, Pichel, Fernando, Almeida, Maria do Céu, Dores, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175587/
https://www.ncbi.nlm.nih.gov/pubmed/35521811
http://dx.doi.org/10.1530/EC-21-0540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175587/
https://www.ncbi.nlm.nih.gov/pubmed/35521811
http://dx.doi.org/10.1530/EC-21-0540

Ejemplares similares